Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series

BACKGROUND: Teprotumumab is a novel treatment that reduces inflammation and symptoms caused by thyroid eye disease. There are limited data on teprotumumab’s effect on intraocular pressure. CASE PRESENTATION: We report nine patients diagnosed with thyroid eye disease whose intraocular pressure decrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Matthew, Sung, Jonathan, Song, Michael, Song, Alice, Song, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087984/
https://www.ncbi.nlm.nih.gov/pubmed/35538553
http://dx.doi.org/10.1186/s13256-022-03375-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087984/
https://www.ncbi.nlm.nih.gov/pubmed/35538553
http://dx.doi.org/10.1186/s13256-022-03375-x

Ejemplares similares